Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07848373) titled 'Contact Lens-Wearing Dry Eye Subjects Who Are Treated With Acoltremon 0.003%' on Sept. 24.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Eye Research Associates, LLC

Condition: Dry Eye Contact Lens Discomfort Eye Drops

Intervention: Drug: acoltremon 0.003%...

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: October 10, 2026

Target Sample Size: 50

To know more, visit https://clinicaltrials.gov/study/NCT07848373

Published by HT Digital Content Servic...